Anti-depressant prescribing patterns for prison inmates with depressive disorders

Jacques Baillargeon, Sandra A. Black, Salvador Contreras, James Grady, John Pulvino

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Although prison inmates are reported to exhibit elevated rates of depressive disorders, little is known about anti-depressant prescribing patterns in correctional institutions. Methods: The study population consisted of 5305 Texas Department of Criminal Justice (TDCJ) inmates who were diagnosed with one of three depressive disorders: major depression, dysthymia, and bipolar disorder (excluding those with manic episodes only). Information on medical conditions, sociodemographic factors, and pharmacotherapy was obtained from an institution-wide medical information system. Results: In 1998, 78.2% of all inmates diagnosed with depressive disorders were treated with antidepressant medication. Of these, 47.3% were treated exclusively with tricyclic anti-depressants (TCA); 30.9% were treated with selective serotonin re-uptake inhibitors (SSRI); and 21.8% were not treated with any form of anti-depressant medication. Prescribing patterns varied substantially according to a number of sociodemographic factors under study. Limitations: Because the present study relied on retrospective, clinical data, the investigators had limited ability to assess: specific symptomatology for each diagnosed depressive condition under study; socio-economic status, pre-incarceration access to health care; and the overall reliability and validity of the data. Conclusion: The proportion of prison inmates with depressive disorders who receive appropriate medication management is substantially higher than that reported among similarly diagnosed nonincarcerated samples. It will be important, however, for future investigators to examine the sources of sociodemographic variation in treatment patterns found in the present study.

Original languageEnglish (US)
Pages (from-to)225-231
Number of pages7
JournalJournal of Affective Disorders
Volume63
Issue number1-3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Prisons
Depressive Disorder
Research Personnel
Criminal Law
Health Services Accessibility
Aptitude
Major Depressive Disorder
Serotonin Uptake Inhibitors
Bipolar Disorder
Information Systems
Reproducibility of Results
Antidepressive Agents
Economics
Depression
Drug Therapy
Population
Therapeutics

Keywords

  • Medication
  • Pharmacoepidemiology
  • Prisoners

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Anti-depressant prescribing patterns for prison inmates with depressive disorders. / Baillargeon, Jacques; Black, Sandra A.; Contreras, Salvador; Grady, James; Pulvino, John.

In: Journal of Affective Disorders, Vol. 63, No. 1-3, 2001, p. 225-231.

Research output: Contribution to journalArticle

Baillargeon, Jacques ; Black, Sandra A. ; Contreras, Salvador ; Grady, James ; Pulvino, John. / Anti-depressant prescribing patterns for prison inmates with depressive disorders. In: Journal of Affective Disorders. 2001 ; Vol. 63, No. 1-3. pp. 225-231.
@article{0b284aa21d214d5ea31208f32990bbc2,
title = "Anti-depressant prescribing patterns for prison inmates with depressive disorders",
abstract = "Background: Although prison inmates are reported to exhibit elevated rates of depressive disorders, little is known about anti-depressant prescribing patterns in correctional institutions. Methods: The study population consisted of 5305 Texas Department of Criminal Justice (TDCJ) inmates who were diagnosed with one of three depressive disorders: major depression, dysthymia, and bipolar disorder (excluding those with manic episodes only). Information on medical conditions, sociodemographic factors, and pharmacotherapy was obtained from an institution-wide medical information system. Results: In 1998, 78.2{\%} of all inmates diagnosed with depressive disorders were treated with antidepressant medication. Of these, 47.3{\%} were treated exclusively with tricyclic anti-depressants (TCA); 30.9{\%} were treated with selective serotonin re-uptake inhibitors (SSRI); and 21.8{\%} were not treated with any form of anti-depressant medication. Prescribing patterns varied substantially according to a number of sociodemographic factors under study. Limitations: Because the present study relied on retrospective, clinical data, the investigators had limited ability to assess: specific symptomatology for each diagnosed depressive condition under study; socio-economic status, pre-incarceration access to health care; and the overall reliability and validity of the data. Conclusion: The proportion of prison inmates with depressive disorders who receive appropriate medication management is substantially higher than that reported among similarly diagnosed nonincarcerated samples. It will be important, however, for future investigators to examine the sources of sociodemographic variation in treatment patterns found in the present study.",
keywords = "Medication, Pharmacoepidemiology, Prisoners",
author = "Jacques Baillargeon and Black, {Sandra A.} and Salvador Contreras and James Grady and John Pulvino",
year = "2001",
doi = "10.1016/S0165-0327(00)00188-9",
language = "English (US)",
volume = "63",
pages = "225--231",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Anti-depressant prescribing patterns for prison inmates with depressive disorders

AU - Baillargeon, Jacques

AU - Black, Sandra A.

AU - Contreras, Salvador

AU - Grady, James

AU - Pulvino, John

PY - 2001

Y1 - 2001

N2 - Background: Although prison inmates are reported to exhibit elevated rates of depressive disorders, little is known about anti-depressant prescribing patterns in correctional institutions. Methods: The study population consisted of 5305 Texas Department of Criminal Justice (TDCJ) inmates who were diagnosed with one of three depressive disorders: major depression, dysthymia, and bipolar disorder (excluding those with manic episodes only). Information on medical conditions, sociodemographic factors, and pharmacotherapy was obtained from an institution-wide medical information system. Results: In 1998, 78.2% of all inmates diagnosed with depressive disorders were treated with antidepressant medication. Of these, 47.3% were treated exclusively with tricyclic anti-depressants (TCA); 30.9% were treated with selective serotonin re-uptake inhibitors (SSRI); and 21.8% were not treated with any form of anti-depressant medication. Prescribing patterns varied substantially according to a number of sociodemographic factors under study. Limitations: Because the present study relied on retrospective, clinical data, the investigators had limited ability to assess: specific symptomatology for each diagnosed depressive condition under study; socio-economic status, pre-incarceration access to health care; and the overall reliability and validity of the data. Conclusion: The proportion of prison inmates with depressive disorders who receive appropriate medication management is substantially higher than that reported among similarly diagnosed nonincarcerated samples. It will be important, however, for future investigators to examine the sources of sociodemographic variation in treatment patterns found in the present study.

AB - Background: Although prison inmates are reported to exhibit elevated rates of depressive disorders, little is known about anti-depressant prescribing patterns in correctional institutions. Methods: The study population consisted of 5305 Texas Department of Criminal Justice (TDCJ) inmates who were diagnosed with one of three depressive disorders: major depression, dysthymia, and bipolar disorder (excluding those with manic episodes only). Information on medical conditions, sociodemographic factors, and pharmacotherapy was obtained from an institution-wide medical information system. Results: In 1998, 78.2% of all inmates diagnosed with depressive disorders were treated with antidepressant medication. Of these, 47.3% were treated exclusively with tricyclic anti-depressants (TCA); 30.9% were treated with selective serotonin re-uptake inhibitors (SSRI); and 21.8% were not treated with any form of anti-depressant medication. Prescribing patterns varied substantially according to a number of sociodemographic factors under study. Limitations: Because the present study relied on retrospective, clinical data, the investigators had limited ability to assess: specific symptomatology for each diagnosed depressive condition under study; socio-economic status, pre-incarceration access to health care; and the overall reliability and validity of the data. Conclusion: The proportion of prison inmates with depressive disorders who receive appropriate medication management is substantially higher than that reported among similarly diagnosed nonincarcerated samples. It will be important, however, for future investigators to examine the sources of sociodemographic variation in treatment patterns found in the present study.

KW - Medication

KW - Pharmacoepidemiology

KW - Prisoners

UR - http://www.scopus.com/inward/record.url?scp=0035089567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035089567&partnerID=8YFLogxK

U2 - 10.1016/S0165-0327(00)00188-9

DO - 10.1016/S0165-0327(00)00188-9

M3 - Article

VL - 63

SP - 225

EP - 231

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -